Sugi Predict

Sugi Predict / Compounds / SCHEMBL527210

SCHEMBL527210

SCHEMBL527210

C(#Cc1cn[nH]c1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.52
▸ GRM5 P41594 8/20 0.48
▸ AKT1 P31749 1/20 0.48
▸ AKT2 P31751 1/20 0.48
▸ HAO1 Q9UJM8 2/20 0.46
▸ MAPT P10636 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ TP53 P04637 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31504928 0.89 HAO1 (0.49) APPGRM5AKT1AKT2HAO1
SCHEMBL6679271 0.82 ROCK2 (0.50) HAO1MAPTKDM4EMEN1NPC1
SCHEMBL24214446 0.77 PIK3CA (0.47) HAO1MAPTCYP3A4RAB9A
SCHEMBL19120100 0.77 GRM5 (0.51) GRM5
SCHEMBL20578549 0.77 KCNH2 (0.40) AKT1AKT2HAO1
SCHEMBL14625514 0.75 HAO1 (0.49) HAO1MAPTKDM4E
SCHEMBL925570 0.73 — —
SCHEMBL20409158 0.73 — —
Diphenylacetylene SCHEMBL960609 0.72 APP (1.00) APPGRM5MAPTKDM4EMEN1
Diphenylacetylene SCHEMBL29188592 0.72 APP (1.00) APPGRM5MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11786575-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-17 — — US disclosed
US-11786575-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-17 — — US disclosed
US-11786575-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-17 — — US disclosed
CN-111741956-B Antiparasitic depsipeptides 硕腾服务有限责任公司 2023-07-07 — — CN disclosed
US-20220211802-A1 Endoparasitic Depsipeptides ZOETIS SERVICES LLC 2022-07-07 — — US disclosed
US-20220211802-A1 Endoparasitic Depsipeptides ZOETIS SERVICES LLC 2022-07-07 — — US disclosed
US-11331369-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2022-05-17 — — US disclosed
US-11331369-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2022-05-17 — — US disclosed
EP-3717478-A1 ENDOPARASITIC DEPSIPEPTIDES Zoetis Services LLC (US) 2020-10-07 — — EP disclosed
CN-111741956-A Antiparasitic depsipeptides 硕腾服务有限责任公司 2020-10-02 — — CN disclosed
US-20130123244-A1 Hetero-Bicyclic Derivatives as HCV Inhibitors JANSSEN R&D IRELAND (IL) 2013-05-16 — — US disclosed
EP-2496572-A1 BENZIMIDAZOLE-IMIDAZOLE DERIVATIVES Janssen R&D Ireland (IE) 2012-09-12 — — EP disclosed
US-20120219594-A1 Benzimidazole-imidazole Derivatives JANSSEN SCIENCES IRELAND UC (IE) 2012-08-30 — — US disclosed
EP-2473503-A1 BIS-BENZIMIDAZOLE DERIVATIVES Janssen R&D Ireland (IE) 2012-07-11 — — EP disclosed
US-20120172368-A1 Bis-Benzimidazole Derivatives TIBOTEC BVBA (IE) 2012-07-05 — — US disclosed
US-20120136027-A1 Phenyl Ethynyl Derivatives As Hepatitis C Virus Inhibitors JANSSEN SCIENCES IRELAND UC (IE) 2012-05-31 — — US disclosed
US-20120135953-A1 Bis-Benzimidazole Derivatives As Hepatitis C Virus Inhibitors TIBOTEC PHARMACEUTICALS (IE) 2012-05-31 — — US disclosed
WO-2012013643-A1 HETERO-BICYCLIC DERIVATIVES AS HCV INHIBITORS TIBOTEC PHARMACEUTICALS (IE) 2012-02-02 — — WO disclosed
WO-2011054834-A1 BENZIMIDAZOLE-IMIDAZOLE DERIVATIVES TIBOTEC PHARMACEUTICALS (IE) 2011-05-12 — — WO disclosed
WO-2011026920-A1 BIS-BENZIMIDAZOLE DERIVATIVES TIBOTEC PHARMACEUTICALS (IE) 2011-03-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11786575-B2 Endoparasitic depsipeptides VIP, PREP, NGLY1 APP 2713/4885GRM5 4236/4885AKT1 2424/4885
US-20220211802-A1 Endoparasitic Depsipeptides VIP, PREP, NGLY1 APP 2713/4885GRM5 4236/4885AKT1 2424/4885
US-20120172368-A1 Bis-Benzimidazole Derivatives CCNI, EIF2AK2, POLRMT APP 4774/4885GRM5 4600/4885AKT1 2868/4885
US-11331369-B2 Endoparasitic depsipeptides VIP, PREP, NGLY1 APP 2713/4885GRM5 4236/4885AKT1 2424/4885
US-20120135953-A1 Bis-Benzimidazole Derivatives As Hepatitis C Virus Inhibitors HAVCR2, ZC3HAV1, CCNI APP 4823/4885GRM5 4634/4885AKT1 2447/4885
US-20120136027-A1 Phenyl Ethynyl Derivatives As Hepatitis C Virus Inhibitors HAVCR2, ZC3HAV1, EIF2AK2 APP 3926/4885GRM5 4735/4885AKT1 2989/4885
US-20120219594-A1 Benzimidazole-imidazole Derivatives HAVCR2, CBR3, ZC3HAV1 APP 4845/4885GRM5 3924/4885AKT1 3567/4885
US-20130123244-A1 Hetero-Bicyclic Derivatives as HCV Inhibitors HAVCR2, ZC3HAV1, SUB1 APP 4823/4885GRM5 4588/4885AKT1 2393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.